Naringenin was found to improve spatial learning and memory deficiency in the AD model; this effect was thought to be mediated through regulation of the PI3K/AKT/GSK-3β pathway and downregulation of Tau phosphorylation [82]. This evidence concerns the gene AKT1 and Alzheimer disease.